Skip to Main Content

Author Details

John Thoms
Memorial University
2008
21
12
PMIDPaper TitleJournal TitlePublished Year
34330793Androgen deprivation therapy and radiation for prostate cancer-cognitive impairment, sleep, symptom burden: a prospective study.BMJ Support Palliat Care2023
34411294A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.Cancer2021
33588077Rationale and protocol for a randomized waitlist controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors.Contemp Clin Trials2021
30625410A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.Int J Radiat Oncol Biol Phys2019
31412701Evaluating the experience of rural individuals with prostate and breast cancer participating in research via telehealth.Rural Remote Health2019
28924059PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy.J Clin Pathol2018
28427756Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.Radiother Oncol2017
27376131Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.Bladder Cancer2016
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
22120718IDH mutation status in prostate cancer.Oncogene2012
22871886Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response.Br J Cancer2012
22405699Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy.Eur J Cancer2012
22048240NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.Clin Cancer Res2012
21178999Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.Nat Rev Clin Oncol2011
21722982Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T.Radiother Oncol2011
20206029Response to "Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects" (Int J Radiat Oncol Biol Phys 2009; in press).Int J Radiat Oncol Biol Phys2010
20814819The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.Breast Cancer Res Treat2010
20832013DNA repair targeting and radiotherapy: a focus on the therapeutic ratio.Semin Radiat Oncol2010
20590366Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.Acta Oncol2010
19887601Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer.Cancer Res2009
18935926A young woman with distant recurrent metastatic primary vaginal carcinoma salvaged with radical radiotherapy.Oncology (Williston Park)2008
  • 1 - 21 of 21

Recommended Authors

University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 7
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 4
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2010
Number of shared co-authors 13
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 3
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 4
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 4
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 8
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 12
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 10
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 2
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 14
Oslo University Hospital
Career Start Year 1999
Number of shared co-authors 3
Stanford University
Career Start Year 1999
Number of shared co-authors 2
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 14
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 9
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 20
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 12
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 2
University Hospital La Princesa
Career Start Year 1995
Number of shared co-authors 6
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 2
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 4
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 4
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 3
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 15
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 5
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 9
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 7

Collaborators

University of Toronto
Co-authored papers 13
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University Health Network, University of Toronto
Co-authored papers 5
St. Michael's Hospital, University of Toronto
Co-authored papers 4
Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 3
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 3
University of Toronto
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
University of Miami Miller School of Medicine
Co-authored papers 3
Tufts University School of Medicine
Co-authored papers 3
University of British Columbia
Co-authored papers 2
British Columbia Cancer Research Institute
Co-authored papers 2
BC Cancer Research Centre
Co-authored papers 2
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 2
University Health Network
Co-authored papers 2
Schroeder Arthritis Institute
Co-authored papers 2
University of Sao Paulo
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 1
University Health Network, University of Toronto
Co-authored papers 1
Cross Cancer Institute
Co-authored papers 1
University of Oxford
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 1
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of British Columbia
Co-authored papers 1